This article reports hopeful histories of healthcare sector stocks tallied as of market closing prices April 26 using Dow dividend dog methodology. This report series started applying dog methods in the fall of 2011 to reveal possible buy opportunities in each of eight major market sectors listed by Yahoo Finance: basic materials (BasMats), consumer goods (ConGo), financials (Fins), healthcare (Heal), industrial goods (IndiGo), services (Svcs), technology (Tec), and utilities (Utes).
Below dog theory picks reporting the highest yield (dividend / price) from Yahoo sectors were supplemented with one year mean target price estimates from broker analysts. These compose the following Arnold healthcare sector selections for April.
Dog Metrics Find Ten Top Healthcare Stocks
Four industries were represented by the ten healthcare sector stocks showing highest dividend yields as of April 26 by Yahoo Finance. February's top healthcare sector stock, Daxor Corporation (DXR), the only medical instruments and supplies firm in the top ten, placed second. PetMed Express (PETS), in third represented drug delivery firms. Meridian Bioscience, Inc. (VIVO) in fifth place represented diagnostic substance firms. The top dog was one of eight drug manufacturers, major on this list, AstraZeneca (AZN). The other major manufacturers were: GlaxoSmithKline (GSK) in fourth position; Merck (MRK) in sixth; Bristol-Myers Squibb Company (BMY), seventh; Eli Lilly and Company (LLY) in eighth; Novartis AG (NVS) in ninth; Pfizer, Inc. (PFE), in tenth completed the top ten healthcare dogs.
Dividend vs. Price Results Compared to Dow Dogs
Below is a graph of the relative strengths of the top ten healthcare dogs by yield as of market close 4/26/2013 compared to those of the Dow. Historic projected annual dividend history from $1000 invested in each of the ten highest yielding stocks and the total single share prices of those ten stocks created the data points shown in green for price and blue for dividends.
Actionable Conclusion (1): Healthcare Dogs Flashed Mixed Signal as Dow Stayed Bullish
The Healthcare collection of dividend payers ended a bullish price course set since October, 2012 as total single share price dropped 2% since March. Aggregate dividend from $10k invested in each of the top ten healthcare stocks, also dropped but at a rate of 4% last month.
The Dow dogs, meanwhile remained totally bullish as price popped up 7% while dividend sank 3.8%. The Dow extended an overbought condition as aggregated single share price exceeded dividend from $1k invested in each stock by $140.52 or 38%.
Since sector dogs are not the blue chip high quality equivalents of the Dow list, an additional gauge of upside potential was added to the simple high yield metric used to sniff out bargains.
Wall Street Wizard Wisdom Weighed
One year mean target price set by analysts multiplied by the number of shares in a $1k investment were used to compare nine stocks showing the highest upside price potential into 2014 out of 20 selected by yield. The number of analysts providing price estimates was noted after the name for each stock. Three to nine analysts was considered optimal for a valid mean target price estimate.
Actionable Conclusion Too (2): Analysts See 9.67% Net Gain from Top 20 Dogs Come 2014
Top twenty dogs for the healthcare sector were graphed below to show relative strengths by dividend and price as of April 26, 2013 and those projected by analyst mean price target estimates to the same date in 2014.
A hypothetical $1000 investment in each equity was divided by the current share price to find the number of shares purchased. The shares number was then multiplied by projected annual per share dividend amounts to find the dividend return. Thereafter the analyst mean target price was used to gauge the stock upsides to 2014.
Historic prices and actual dividends paid from $1000 invested in the ten highest yielding stocks and the aggregate single share prices of those twenty stocks divided by 2 created the data points for 2013. Projections based on estimated increases in dividend amounts from $1000 invested in the twenty highest yielding stocks and aggregate one year analyst target share prices from Yahoo Finance divided by 2 created the 2014 data points green for price and blue for dividends.
Yahoo projected a 2.7% lower dividend from $10K invested in this group while aggregate single share price was projected to increase by over 5% in the coming year. Note that the chart showed an overbought condition for 2014 when aggregate single share price for ten Healthcare dogs exceeded projected dividends from $1k invested in those ten.
The number of analysts contributing to the mean target price estimate for each stock was noted in the last column on the charts. Three to nine analysts was considered optimal for a valid projection estimate. Estimates provided by one analyst were not applied.
Actionable Conclusion Three (3): Analysts Forecast 2014 Health DiviDog Stock Net Gains of 3.45% to 28.65%
Nine probable profit generating trades revealed by Yahoo Finance for 2014 were:
- Herbalife Ltd. Co. (HLF) netted $530.56, based on dividends plus a mean target price estimates by seven analysts less broker fees;
- Sanofi (SNY) netted $293,53, based on dividends plus mean target price estimate from three analysts less broker fees;
- Teva Pharmaceutical (TEVA) netted $171.96 based on dividends plus mean target price estimate from twenty analysts less broker fees;
- Meridien Bioscience, Inc. netted $135.10 based on a mean target price estimate from eight analysts combined with projected annual dividend less broker fees;
- Mine Safety Appliances Co. (MSA) netted $130.80 based on dividend plus a mean target price estimate from four analysts less broker fees;
- Medtronic, Inc. (MDT) netted $78.36 based on estimates from seventeen analysts plus dividends less broker fees.
- Baxter International, Inc. (BAX) netted $74.69 based on estimates from fifteen analysts plus dividends less broker fees;
- Merck & Co. Inc. netted $69.41 based on dividends plus the mean of annual price estimates from fifteen analysts less broker fees.
- Pfizer Inc. netted $47.46 based on dividends plus the mean of annual price estimates from seventeen analysts less broker fees.
The average net gain in dividend and price was 17% on $1k invested in each of these nine dogs.
The stocks listed above are suggested only as decent starting points for your sector dividend stock purchase research process. These are not recommendations.
Disclaimer: This article is for informational and educational purposes only and should not be construed to constitute investment advice. Nothing contained herein shall constitute a solicitation, recommendation or endorsement to buy or sell any security. Prices and returns on equities in this article except as noted are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling same.